Cargando…
Almotriptan 12.5 mg in menstrually related migraine: A randomized, double-blind, placebo-controlled study
Background: Menstrually related migraine (MRM) affects more than half of female migraineurs. Because such migraines are often predictable, they provide a suitable target for treatment in the mild pain phase. The present study was designed to provide prospective data on the efficacy of almotriptan fo...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057443/ https://www.ncbi.nlm.nih.gov/pubmed/20660540 http://dx.doi.org/10.1177/0333102410378048 |